Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions
Authors
Keywords
-
Journal
CEPHALALGIA
Volume 39, Issue 14, Pages 1798-1808
Publisher
SAGE Publications
Online
2019-11-11
DOI
10.1177/0333102419888222
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
- (2019) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Erenumab: A First-in-Class Monoclonal Antibody for Migraine Prevention
- (2019) Scott G. Garland et al. ANNALS OF PHARMACOTHERAPY
- Erenumab in chronic migraine with medication overuse
- (2019) Stewart J. Tepper et al. NEUROLOGY
- Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine
- (2019) Jeanine L. Bussiere et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Phase 1, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the effects of erenumab (AMG 334) and concomitant sumatriptan on blood pressure in healthy volunteers
- (2018) Jan de Hoon et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina
- (2018) Christophe Depre et al. HEADACHE
- Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design
- (2017) Daniel Serrano et al. JOURNAL OF HEADACHE AND PAIN
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- Erenumab (AMG 334) in episodic migraine
- (2017) Messoud Ashina et al. NEUROLOGY
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Hong Sun et al. LANCET NEUROLOGY
- Gastrointestinal disorders associated with migraine: A comprehensive review
- (2016) Carlos R Cámara-Lemarroy et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The FDA's Final Rule on Expedited Safety Reporting: Statistical Considerations
- (2015) Janet Wittes et al. Statistics in Biopharmaceutical Research
- Association between migraine and irritable bowel syndrome: a population-based retrospective cohort study
- (2014) C.-I. Lau et al. EUROPEAN JOURNAL OF NEUROLOGY
- Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)
- (2013) Andrew M. Blumenfeld et al. HEADACHE
- The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison With Other Recent Clinical Practice Guidelines
- (2012) Elizabeth Loder et al. HEADACHE
- Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) in human gastrointestinal tract
- (2012) Graeme S. Cottrell et al. PEPTIDES
- Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team
- (2009) Brenda J Crowe et al. Clinical Trials
- Calcitonin Gene-Related Peptide Receptor Antagonism Does Not Affect the Severity of Myocardial Ischemia during Atrial Pacing in Dogs with Coronary Artery Stenosis
- (2008) C. P. Regan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started